论文部分内容阅读
10余年来,随着非小细胞肺癌(NSCLC)化疗药物研究的深入研发,第三代化疗药物相继问世,临床应用收到良好的疗效。本文就其在NSCLC化疗进展作一综述。
More than 10 years, with the further research and development of chemotherapeutic drugs for non-small cell lung cancer (NSCLC), the third generation of chemotherapeutic drugs have come out in succession and have received good clinical effects. This article reviews the progress of chemotherapy in NSCLC.